Spelling suggestions: "subject:"sentinel lymph none biopsy."" "subject:"sentinel lymph note biopsy.""
1 |
Patterns of lymph node biopsy pathology Chris Hani Baragwanath academic hospital over a period of three years 2010-2012Reddy, Denasha Lavanya January 2015 (has links)
A research report submitted to the Faculty of Health Sciences, University of
Witwatersrand, in fulfillment of the requirements for the degree of Master of Medicine in
the branch of Internal Medicine
Johannesburg, 2015 / Lymphadenopathy is a common clinical presentation of disease in South Africa (SA),
particularly in the era of Human Immunodeficiency Virus (HIV) and tuberculosis (TB) coinfection.
Methods
Data from 560 lymph node biopsy reports of specimens from patients older than 12
years at Chris Hani Baragwanath Academic Hospital (CHBAH) between 1 January 2010
and 31 December 2012 was extracted from the National Health Laboratory Service
(NHLS), division of Anatomical Pathology. Cytology reports of lymph node fine needle
aspirates (FNAs) performed prior to lymph node biopsy in 203 patients were also
extracted from the NHLS. Consent was not obtained from participants for their records
to be used as patient information was anonymized and de-identified prior to analysis.
Results
The majority of patients were female (55%) and of the African/black racial group (90%).
The median age of patients was 40 years (range12-94). The most common indication
for biopsy was an uncertain diagnosis (more than two differential diagnoses entertained),
followed by a suspicion for lymphoma, carcinoma and TB. Overall, malignancy
constituted the largest biopsy pathology group (39%), with 36% of this group being
carcinoma and 27% non-Hodgkin lymphoma. 22% of the total sampled nodes displayed
necrotizing granulomatous inflammation (including histopathology and cytology
demonstrating definite, and suspicious for mycobacterial infection), 8% comprised HIV
reactive nodes; in the remainder no specific pathology was identified (nonspecific
reactive lymphoid hyperplasia). Kaposi sarcoma (KS) accounted for 3% of lymph node
pathology in this sample. Concomitant lymph node pathology was diagnosed in four
cases of nodal KS (29% of the subset). The co-existing pathologies were TB and
Castleman disease. HIV-positive patients constituted 49% of this study sample and the
majority (64%) of this subset had CD4 counts less than 350 cells/ul. 27% were HIVnegative
and in the remaining nodes, the HIV status of patients was unknown. The most
common lymph node pathologies in HIV-positive patients were Mycobacterial infection
(31%), HIV reactive nodes (15%), non-Hodgkin lymphoma (15%) and nonspecific
reactive lymphoid hyperplasia (15%). Only 9% were of Hodgkin lymphoma. In contrast,
the most common lymph node pathologies in HIV-negative patients were nonspecific
reactive lymphoid hyperplasia (45%), carcinoma (25%) and Mycobacterial infection
(11%). In this group, non-Hodgkin lymphoma and Hodgkin lymphoma constituted 9%
and 8%, respectively. There were more cases of high-grade non-Hodgkin lymphoma in
the HIV-positive group compared to the HIV-negative group. FNA and lymph node
biopsy had excellent agreement with regard to Hodgkin lymphoma (K 0.774, SE 0.07,
95% CI 0.606-0.882, p=0.001), and good agreement with regard to non-Hodgkin
lymphoma (K 0.640, SE 0.07, 95% CI 0.472-0.807, p=0.001), carcinoma (K 0.723, SE
0.069, 95% CI 0.528-0.918, p=0.001), and mycobacterial infection (K 0.726, SE 0.07,
95% CI 0.618-0.833, p=0.001).
Conclusions
The most common lymph node pathologies in CHBAH are malignancies, nonspecific
reactive lymphoid hyperplasia, necrotizing granulomatous inflammation and HIV reactive
nodes. The distribution of disease differed in HIV-positive patients. Overall, adequate
FNA samples of lymph nodes have been found to have good correlation with lymph
node biopsy findings in our setting.
|
2 |
IdentificaÃÃo de linfonodos sentinela da mama com azul de metileno em modelo canino / Identification of sentinel lymph nodes in breast methylene blue in a canine modelRanieri dos Santos Rolim 17 December 2010 (has links)
CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior / Objetivos. Desenvolver um modelo experimental para identificaÃÃo de linfonodo sentinela (LS) da mama da cadela com uso de corante azul de metileno e comparÃ-lo com o azul patente, controlados por tecnÃcio. MÃtodos. O trabalho foi realizado em 23 cadelas, tendo-se observado a marcaÃÃo dos LS do primeiro par superior de mamas ao se injetarem 0,2 ml de TecnÃcio 99m ligado ao fitato (Tc 99m) e 0,5 ml de azul patente Guerbet V 2,5 % nos espaÃos subpapilares das mamas direitas e 0,2 ml de Tc-99m e 0,5 ml do azul de metileno 1 % nos mesmos espaÃos das mamas esquerdas. Resultados. Na mama direita, as tÃcnicas de biopsia de LS quando utilizados o Tc-99m e azul patente foram concordantes. Dos 23 LS estudados, somente um nÃo corou nem foi captante. O azul patente foi eficaz em 100 % quando comparado com os dois mÃtodos associados. Na mama esquerda, dos 23 LS estudados, somente dois nÃo coraram e um nÃo foi captante, sendo esta diferenÃa estatisticamente nÃo significante. A tÃcnica de biopsia do LS utilizando-se o azul de metileno apresentou-se com eficÃcia de 91,3 % quando utilizado isoladamente e de 100 % quando associado ao Tc-99m. ConclusÃo. O uso do azul de metileno associado ao radiofÃrmaco pode ser considerado como tÃcnica potencial na pesquisa transoperatÃria do LS das mamas, sendo uma opÃÃo menos onerosa e com menores efeitos alergÃnicos do que o azul patente / Objetivos. Desenvolver um modelo experimental para identificaÃÃo de linfonodo sentinela (LS) da mama da cadela com uso de corante azul de metileno e comparÃ-lo com o azul patente, controlados por tecnÃcio. MÃtodos. O trabalho foi realizado em 23 cadelas, tendo-se observado a marcaÃÃo dos LS do primeiro par superior de mamas ao se injetarem 0,2 ml de TecnÃcio 99m ligado ao fitato (Tc 99m) e 0,5 ml de azul patente Guerbet V 2,5 % nos espaÃos subpapilares das mamas direitas e 0,2 ml de Tc-99m e 0,5 ml do azul de metileno 1 % nos mesmos espaÃos das mamas esquerdas. Resultados. Na mama direita, as tÃcnicas de biopsia de LS quando utilizados o Tc-99m e azul patente foram concordantes. Dos 23 LS estudados, somente um nÃo corou nem foi captante. O azul patente foi eficaz em 100 % quando comparado com os dois mÃtodos associados. Na mama esquerda, dos 23 LS estudados, somente dois nÃo coraram e um nÃo foi captante, sendo esta diferenÃa estatisticamente nÃo significante. A tÃcnica de biopsia do LS utilizando-se o azul de metileno apresentou-se com eficÃcia de 91,3 % quando utilizado isoladamente e de 100 % quando associado ao Tc-99m. ConclusÃo. O uso do azul de metileno associado ao radiofÃrmaco pode ser considerado como tÃcnica potencial na pesquisa transoperatÃria do LS das mamas, sendo uma opÃÃo menos onerosa e com menores efeitos alergÃnicos do que o azul patente / Objectives. To develop an experimental model for identification of sentinel lymph node (SLN) of breast bitch with the use of methylene blue and compares it with the patent blue, both associated with technetium. Methods. 23 dogs, there was the marking of the SLN of the first upper pair of breasts to inject 0.2 ml of Tc-99m phytate bound to (99m) and 0.5 ml of patent blue Guerbet V 2,5 % in subpapilar spaces right breast and 0.2 ml of 99mTc and 0.5 ml of 1% methylene blue in the same spaces left breast. Results. In the right breast biopsy techniques using 99mTc SLN and blue dye are in agreement. Of the 23 SLN studied, only one was not flushed nor uptake. The patent blue was effective in 100% when compared with the two methods together. The left breast of 23 SLN studied, only two non-stained and one was not uptake, this difference was not statistically significant. The SLN biopsy technique using methylene blue appeared with a 91.3% effectiveness when used alone and 100% when associated with 99mTc. Conclusion: The use of methylene blue associated with the radiotracer technique can be considered as potential research intraoperative SLN of breast, suggesting a less costly and less allergenic effects that blue patent. / Objectives. To develop an experimental model for identification of sentinel lymph node (SLN) of breast bitch with the use of methylene blue and compares it with the patent blue, both associated with technetium. Methods. 23 dogs, there was the marking of the SLN of the first upper pair of breasts to inject 0.2 ml of Tc-99m phytate bound to (99m) and 0.5 ml of patent blue Guerbet V 2,5 % in subpapilar spaces right breast and 0.2 ml of 99mTc and 0.5 ml of 1% methylene blue in the same spaces left breast. Results. In the right breast biopsy techniques using 99mTc SLN and blue dye are in agreement. Of the 23 SLN studied, only one was not flushed nor uptake. The patent blue was effective in 100% when compared with the two methods together. The left breast of 23 SLN studied, only two non-stained and one was not uptake, this difference was not statistically significant. The SLN biopsy technique using methylene blue appeared with a 91.3% effectiveness when used alone and 100% when associated with 99mTc. Conclusion: The use of methylene blue associated with the radiotracer technique can be considered as potential research intraoperative SLN of breast, suggesting a less costly and less allergenic effects that blue patent.
|
3 |
Sentinel node biopsy in breast cancer : clinical and immunological aspects /de Boniface, Jana, January 2007 (has links)
Diss. (sammanfattning) Uppsala : Uppsala universitet, 2007. / Härtill 4 uppsatser.
|
4 |
Sentinel node biopsy in breast cancer : aspects on validation, diagnostics and lymphatic drainage pattern /Celebioglu, Fuat, January 2006 (has links)
Diss. (sammanfattning) Stockholm : Karolinska institutet, 2006. / Härtill 4 uppsatser.
|
5 |
A influÃncia da incisÃo para-areolar no quadrante superior externo da mama, na localizaÃÃo do linfonodo sentinela em modelo canino / The influence of para-areolar incision in the upper outer quadrant of the breast, the location of the sentinel lymph node in canine modelPaulo Henrique Diogenes Vasques 26 February 2010 (has links)
CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior / Este trabalho aborda a influÃncia da incisÃo para-areolar no quadrante superior externo da mama, na localizaÃÃo do linfonodo sentinela em modelo canino. A BiÃpsia do linfonodo sentinela (BLS) à um mÃtodo de amostragem seletiva, minimamente invasivo, altamente sensÃvel em predizer o estado axilar, podendo evitar o esvaziamento ganglionar em pacientes sem comprometimento metastÃtico. Mulheres, com cirurgias mamÃrias previas, foram excluÃdas da realizaÃÃo da BLS por muitos cirurgiÃes por acreditar que teriam um Ãndice de falso negativo elevado, inviabilizando o mÃtodo. Outros mastologistas passaram a empregar, empiricamente, a injeÃÃo do marcador corante ou radioativo acima da borda da incisÃo prÃvia, porÃm fica a dÃvida se o gÃnglio identificado à realmente o Linfonodo Sentinela (LS). Este trabalho experimental, em modelo canino, tem como objetivo identificar a influÃncia das incisÃes para-areolares prÃvias, no quadrante superior externo (QSE) da mama na identificaÃÃo do linfonodo sentinela. à utilizado o radiocolÃide TecnÃcio99 injetado na derme sub-areolar das mamas torÃcicas craniais, para marcar o LS. Esperado o tempo de migraÃÃo do radiofÃrmaco para axila e identificado o local de marcaÃÃo com probe. Procede-se incisÃo arciforme para- areolar no QSE, entre 9 e 12h à direita e 12 e 3 h à esquerda, a 2cm do mamilo. O corante azul patente Ã, entÃo, injetado na borda superior destas incisÃes. No ponto marcado com o gama-probe à realizada a incisÃo axilar mÃnima, onde o LS à identificado com auxÃlio do probe, que capta a radiaÃÃo do gÃnglio, eou pela visualizaÃÃo direta do linfonodo impregnado com o corante. SÃo comparadas duas tÃcnicas de local de injeÃÃo e a concordÃncia entre os mÃtodos de identificaÃÃo do LS. Os experimentos da pesquisa ocorreram entre Janeiro 2008 e Maio 2009. A amostra à composta de 40 mamas torÃcicas craniais, oriundas de 23 cadelas adultas, sem raÃa definida, da espÃcie Canis familiaris. A anÃlise estatÃstica foi realizada com o auxÃlio do programa Graphpad e utilizados o Teste de McNemar e Coeficiente de ConcordÃncia de Kappa. Os resultados demonstram que em 95% das mamas estudadas (3840) obtiveram o LS identificado na axila apÃs a injeÃÃo de tecnÃcio na regiÃo subareolar e em 82% dos casos (33/40) coraram com azul patente injetado no bordo superior da incisÃo padronizada. Os resultados obtidos indicam a concordÃncia entre os mÃtodos em 82% dos casos na identificaÃÃo do LS (3340). As incisÃes para-areolares prÃvias, nos quadrantes superiores externos, das mamas torÃcicas craniais da cadela, nÃo demonstram interferir, de maneira significante, na BLS quando o corante à injetado na borda superior da incisÃo. O linfonodo encontrado a partir de injeÃÃo na borda superior da incisÃo previa, corresponde ao linfonodo sentinela da mama da cadela, em 95% dos casos (3233). / This paper discusses the influence of para-areolar incision in the upper outer quadrant of the breast for the location of the sentinel lymph node in canine model. Sentinel lymph node biopsy (SLNB)―a minimally invasive selective sampling technique highly predictive of the condition of the armpit―can spare metastasis-free patients from unnecessary axillary dissection. The high incidence of false-negative results has led many surgeons to no longer indicate SLNB to women with previous breast surgery. Some mastologists prefer to empirically inject a dye or radio-labelled marker above the border of the previous incision, though it is not always clear if the identified ganglion is in fact the sentinel lymph node. The objective of the present study was to evaluate the influence of previous para-areolar incisions in the upper outer quadrant (UOQ) of the breast upon the identification of the sentinel lymph node (SLN) in a canine model. The SLN was marked with Technetium-99m (99mTc) injected into the subareolar skin of the cranial breast. Once the marker had migrated to the axilla and the marked site had been identified with a gamma probe, an arcuate para-areolar incision was performed 2 cm from the nipple in the UOQ (between the 9 and 12 oâclock position on the right side, and between the 12 and 3 oâclock position on the left side). Patent blue dye was then injected above the upper border of the incision. At the marked site a minimal axillary incision was made and the SLN was identified by gamma probe and/or by direct visualization of the dye. The agreement between the two injection sites and the two SLN identification methods was determined. The experiments were carried out between January 2008 and May 2009 on a sample of 40 cranial breasts of 23 adult females of the species Canis familiaris. Using the statistics software Graphpad, the data were submitted to the McNemar test and the Kappa agreement coefficient was calculated. Our findings show that in 95% (38/40) of the breasts the SLN was identified by injection of 99mTc in the subareolar region, and that in 82% (33/40) of cases the SLN was identified by injection of patent blue dye above the upper border of the incision. Thus, the methods agreed in 82% (33/40) of cases. Previous para-areolar incisions in the UOQ of the cranial breasts did not interfere significantly with the biopsy when the dye was injected above the upper border of the incision. The lymph node identified by injection above the upper border of the previous incision corresponded to the SLN in 95% (32/33) of cases.
|
6 |
Modelo Experimental em Caninos para a Pesquisa de Linfonodo Sentinela do EstÃmago / Experimental Model in Canines for Research Sentinel node StomachJose Ricardo de Moura Torres de Melo 26 February 2010 (has links)
CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior / A gastrectomia com linfadenectomia ampliada ainda à o padrÃo ouro para o tratamento curativo do cÃncer de estÃmago (CaE), embora este procedimento possa levar a alto Ãndice de morbidade ou mortalidade, principalmente nos pacientes que nÃo apresentem disseminaÃÃo linfÃtica da doenÃa. A pesquisa do linfonodo sentinela (LS), jà consagrada nos tumores iniciais de mama e nos melanomas, apresenta-se cada vez mais freqÃente no trato digestÃrio, em especial no CaE com resultados animadores. Estudos iniciados nos meados do ano 2000 retratam busca crescente e bastante prÃspera para esclarecimento desta questÃo. O objetivo deste trabalho à elaborar um modelo experimental que possa demonstrar tecnicamente, em laboratÃrio, a viabilidade da pesquisa do LS no antro gÃstrico da cadela. Foram estudadas 25 cadelas com peso aproximado de 11 Kg e idade de 01 a 02 anos, sem raÃa definida (SRD), clinicamente saudÃveis, proveniente do Centro de Controle de Zoonoses do MunicÃpio de Fortaleza (CCZ) que tinham programaÃÃo para eutanÃsia. Com escolha aleatÃria, estes animais foram estudados individualmente e semanalmente. Utilizou-se, separadamente, TecnÃcio (99mTc) com traÃador/colÃide Fitato e corante vital azul patente V Guerbert 2,5 % (AP) injetados a 01 cm do piloro, na pequena curvatura no antro gÃstrico da cadela e analisados nos tempos zero, 05, 10, 15 e 20 minutos. ApÃs este perÃodo realizou-se pesquisa âin vivoâ do local de injeÃÃo do marcador e linfonodos encontrados e âex-vivoâ destes linfonodos. Para o estudo com o 99mTc utilizou-se o aparelho Gamma Probe modelo Nuclearlab DGC-II - detector para cirurgia radioguiada e sonda captadora de irradiaÃÃo acoplada com unidade de contagem e rastreamento sonoro e para o AP, visÃo direta. Para a anÃlise estatÃstica utilizou-se o teste de McNemar e o Coeficiente de ConcordÃncia de Kappa. Foi estabelecido em 5% o nÃvel de significÃncia (p≤0,05). Com o uso do 99mTc isolado foi identificado a presenÃa do LS em 20 animais (80%). Quando se utilizou o corante AP isolado a presenÃa do LS foi identificada em 24 animais (96 %). NÃo houve significÃncia estatÃstica quanto ao uso destes marcadores para a pesquisa do LS no antro gÃstrico da cadela. Concluiu-se que (1) O estÃmago da cadela à adequado para modelo experimental de pesquisa âin vivoâ do linfonodo sentinela e (2) O tecnÃcio (99mTc) e corante vital â azul patente V Guerbert 2,5 % (AP) sÃo eficientes como marcadores de linfonodo sentinela do antro gÃstrico da cadela. / The gastrectomy with extensive lymphadenectomy still is the gold standard for the dressing treatment of the gastric cancer (GC), even so these procedures can take high index of morbidity or mortality, mainly in the patients who do not present lymphatic dissemination of the illness. The research of sentinel lymph node (SLN), already consecrated in the initial tumors of breast and the melanomas, presents each time more frequent for upper gastrointestinal cancers, specially in GC with encouraging results. Studies initiated in the middles of 2000 portray increasing and sufficiently prosperous search for clarification of this question. The objective of this work is to elaborate an experimental model that can demonstrate technically, in laboratory, the research viability of SLN in gastric antrum of the dog. 25 female dogs had been studied with approach weight of 11 kg and age of 01/02 years, without definite race (WDR), healthful clinically, proceeding from the Control Center of Zoonosis of Fortaleza City with programming for euthanasia. With random choice, these animals had been studied individually and weekly. It was used, separately, radioisotopic 99mtechnetium labeled phytate and patent blue dye (V Guerbert 2.5%) injected at 01 cm above the piloro, on the small bending in the antrum gastric of the dog and analyzed in the times zero, 05, 10, 15 and 20 minutes. After this period, the injection place of the markers and gastric lymph nodes were appraised âin vivoâ (in the animal) and the gastric lymph nodes âex vivoâ (out of the animal). For the study with the 99mtechnetium it was used the device Gamma Probe model Nuclearlab DGC-II (radioguiada surgery with sounding lead of irradiation connected to unit of counting and sonorous tracking) and for the patent blue dye, direct vision. For the analysis statistics were used the test of McNemar and the Quantify agreement with Kappa. The level of significance was established in 5% (p≤0,05). When the radioisotopic 99mtechnetium labeled phytate was used single, the LS was identified in 20 animals (80%). With the patent blue dye single, in 24 animals (96%). There is no statistic significance with the use of those markers for the LS research in the gastric antrum of the dog. The conclusions are (1) The stomach of the dog is adjusted for experimental model in alive research of the sentinel lymph node (2) The radioisotopic 99mtechnetium labeled phytate and patent blue dye (V Guerbert 2.5%) are efficients as markers of sentinel lymph node of the dogâs gastric antrum.
|
7 |
Biópsia de linfonodo sentinela na recidiva locorregional do melanoma maligno revisão sistemática /Peres, Gabriel. January 2020 (has links)
Orientador: Antônio José Maria Cataneo / Resumo: Introdução: No melanoma primário, a aplicabilidade da biópsia de linfonodo sentinela (BLS), seguida ou não de esvazimento linfonodal (EL) é conhecida. Na recidiva locorregional (RL) de melanoma, alguns serviços tendem a indicá-la, buscando estadiamento mais acurado para embasar condutas individualizadas aos pacientes, ainda que as evidências sejam insuficientes. Objetivo: Avaliar o sucesso da BLS no encontro do linfonodo sentinela (LNS) e sua positividade na RL. Comparar a sobrevida entre os pacientes com LNS positivo e negativo. Verificar diferença na sobrevida pós EL. Métodos: Revisão sistemática, através das bases MEDLINE via PUBMED, LILACS, SCOPUS, EMBASE e CENTRAL, buscando estudos experimentais e observacionais sobre BLS na RL de melanoma. Desfechos avaliados: sucesso na BLS pelo encontro do LNS, positividade para melanoma no LNS; sobrevida no subgrupo LNS positivo comparado com o negativo; sobrevida livre de doença no subgrupo LNS positivo comparada com o negativo; sobrevida dos pacientes submetidos ao EL. Para metanálises, utilizaram-se RevMan 5.3 e StatsDirect 3.0.121. Resultados: Foram identificados 1872 estudos, destes, seis estudos observacionais foram incluídos, totalizando 449 pacientes. O LNS foi encontrado em 98% das BLS (IC 95-100%, I2=53,7% - seis estudos). LNS com 32% de positividade para melanoma (IC 19-47%, I2= 84,6% - seis estudos). A chance de sobrevida global em cinco anos foi 2,49 vezes maior no subgrupo com LNS negativo (IC 95% 1,41-4,38, I2=0% - qua... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Background: In primary melanoma, the applicability of sentinel lymph node biopsy (SLB), followed or not by complete lymph node dissection (CLND) is known. In locoregional recurrence (LR) of melanoma, some groups may indicate it for more accurate staging to support individualized management, even with scarce evidence. Objective: To evaluate success in SLB and its positivity in LR. Compare survival between patients with positive and negative sentinel lymph node (SLN). Check for survival modification after CLND. Methods: Systematic review through databases such as MEDLINE via PUBMED, LILACS, SCOPUS, EMBASE and CENTRAL, searching for experimental and observational studies on SLB in melanoma LR. Outcomes assessed: success in SLB by finding the SLN, positivity for melanoma in the SLN; survival in the positive SLN subgroup compared to the negative one; disease-free survival in the positive versus negative SLN subgroup; survival of patients undergoing CLND. For meta-analyzes, RevMan 5.3 and StatsDirect 3.0.121 were used. Results: The total number of patients in six observational studies was 449, over 1872 studies indentified. The SNL was found in 98% of SLB (95-100% CI, I2 = 53.7%, 6 studies). SLB detected 32% positivity for melanoma on SNL (CI 19-47%, I2 = 84.6%, 6 studies). The chance of five year overall survival was 2,49 higher in the negative SNL subgroup (95% CI 1.41-4.38, I2 = 0%, 4 studies). Meta-analyzes were not performed due to lack of objective data for disease-free survi... (Complete abstract click electronic access below) / Doutor
|
8 |
Sentinel Lymph Node Involvement by Epithelial Inclusions Mimicking Metastatic Carcinoma: A Diagnostic PitfallSigei, Asha C., Bartow, Brooke B., Wheeler, Yurong 01 January 2020 (has links)
Objective: Background: Rare disease An epithelial inclusion cyst within a lymph node denotes a heterotopic phenomenon. Nodal epithelial inclusion cysts have been reported in a variety of anatomical locations including pelvic, abdominal, mediastinal, and axillary regions. While nodal melanocytic nevus (also known as nevus cell aggregates) is the most common heterotopic phenomena involving the axillary lymph nodes, the presence of benign epithelial inclusion cysts in axillary lymph nodes is a rare but well-reported finding. Such documentation is in part due to assessment of sentinel lymph nodes in breast cancer becoming standard of care. These epithelial inclusion cysts offer a diagnostic pitfall in evaluation of sentinel lymph node in the setting of breast carcinoma. They also complicate assessment of sentinel lymph node during intraoperative frozen sections analysis. Case Report: We report a case of co-existent of benign squamous-type and glandular-type epithelial inclusions cysts in 2 sentinel lymph nodes in a patient with grade III invasive ductal carcinoma involving the left breast. There have been at least 4 cases reported in literature in which benign epithelial inclusion cysts in sentinel lymph nodes were first mistakenly diagnosed as metastatic carcinoma both during intraoperative frozen section analysis and during review of permanent sections. The missed diagnosis could potentially occur intraoperatively during frozen section sentinel lymph node analysis secondarily due to lack of availability of the primary tumor for comparison and inability to use immunohistochemical stains. Conclusions: Pathologists should be aware of this pitfall especially in frozen section analysis of sentinel lymph node to avoid misdiagnosis and its associated potential grave consequences.
|
9 |
Extensão do comprometimento axilar após biópsia de linfonodo sentinela positivo nas pacientes com câncer de mama operadas no Hospital de Clínicas de Porto AlegreFontana, Vivian January 2017 (has links)
Introdução: o status dos linfonodos axilares permanece um dos mais importantes fatores prognósticos no carcinoma de mama em estágios iniciais, além de definir o uso de terapias complementares. A biópsia de linfonodo sentinela (BLNS) surgiu com a finalidade de estadiar a axila com o mínimo de morbidade, tendo como objetivo a identificação e o estudo patológico do primeiro linfonodo axilar proveniente da drenagem linfática da mama. Pacientes com axila clinicamente negativa têm indicação de biópsia de linfonodo sentinela como método de estadiamento da axila, e quando o resultado era positivo para metástase recomendava-se o esvaziamento axilar. Por recomendação do ACOSOG Z0011, o esvaziamento axilar (EA) após uma biópsia de linfonodo sentinela positivo não é necessário. Esse estudo demonstrou não haver benefício em realizar o EA na presença de LNS positivo na sobrevida global ou na sobrevida livre de doença. Objetivos: Avaliar a taxa de recidiva e morte em pacientes submetidas à cirurgia conservadora de mama e BLNS positiva com posterior esvaziamento axilar no Hospital de Clínicas de Porto Alegre; e, como objetivo secundário, avaliar as características clínicas e patológicas dessa população. Método: foi realizado um estudo de coorte retrospectiva, incluindo pacientes com diagnóstico de carcinoma de mama invasor submetidas à cirurgia conservadora da mama e BLNS, cujo resultado foi positivo para presença de metástases, e foram submetidas ao EA o período de janeiro de 2004 a dezembro de 2008. Resultados: foram incluídas 144 pacientes submetidas à biópsia de linfonodo sentinela e CCM; 33 tiveram o achado de biópsia de linfonodo sentinela positivo para metástase, e dessas 33 pacientes restaram 27 para análise dos dados. A taxa de sucesso na identificação do LNS foi de 0,96. A idade média das pacientes foi de 53,8 anos, o número de LNS ressecados foi de 1,6 por paciente; a média do tamanho tumoral foi de 2,3 cm. Seis pacientes apresentaram doença axilar residual correspondendo a 22,2% da amostra e tiveram um risco relativo de morte de 3 vezes mais para aquelas sem doença axilar residual e 50% a mais de desenvolvimento de metástases. Conclusão: O comprometimento axilar é importante fator no prognóstico das pacientes com câncer de mama, quanto maior o comprometimento da axilar pior será o desfecho de sobrevida livre de doença e de morte. Acreditamos que se pode aplicar a conduta do ACOSOG Z0011 também nas pacientes do HCPA devido à alta sensibilidade do método no nosso meio. / Introduction: The status of axillary lymph nodes remains one of the most important prognostic factors in breast carcinoma in the early stages, in addition it helps to defining the use of complementary therapies. Sentinel lymph node biopsy (SLNB) was developed with the purpose of staging the axilla with minimal morbidity, aiming at the identification and pathological study of the first axillary lymph node from the lymphatic drainage of the breast. Patients with clinically negative lymph node have indication of SLNB as a method of axillary staging, and with a positive finde for metastasis the axilar clereance was performed. Nowadays, due to the ACOSOG Z0011 Study, the axillary dissection (AD) after a positive SLNB for metastasis was put in check. This estudy have as a result no difference in global survive ou disease free survive if ALND was not performed in a positive SLNB. In the present study, we intend to evaluate the clinical and histopathological characteristics of patients submitted to breast conservative surgery and sentinel lymph node biopsy with a positive result for metastasis. Main objective: Evaluate the rate of recurrence and death in patients submitted to conservative breast surgery and BLNS with posterior axillary emptying at Hospital de Clínicas, Porto Alegre. It is a secondary objective to evaluate the clinical and pathological characteristics of this population. Material and Methods: A retrospective cohort study was performed, including 144 patients diagnosed with invasive breast carcinoma submitted to conservative breast surgery and SLNB, whose results were positive for metastases, and were submitted to AD, at the Mastology Unit of the Hospital de Clinicas de Porto Alegre (HCPA), from January 2004 to December 2008. Results: Of 144 patients submitted to SLNB and BCS, 33 had SLNB positive for metastasis, of these 33 patients remained 27 for data analysis. The success rate in LNS identification was 0.96. The mean age of the patients was 53.8 years, the number of resected SLN was 1.6 per patient; The mean tumor size was 2.3 cm. Six patients had residual axillary disease corresponding to 22.2% of the sample and had a relative risk of death of 3 times more for those without residual axillary disease and 50% more for the development of metastases. Conclusion: Axillary involvement is an important factor in the prognosis of patients with breast cancer, and the greater the axillary impairment, the worse the diseasefree survival outcome and death. We believe that the ACOSOG Z0011 trial can also be applied to HCPA patients who meet the inclusion criteria for this purpose, due to the high sensitivity of the method in our environment.
|
10 |
Pesquisa do Linfonodo Sentinela em Pacientes portadoras de CÃncer de Mama localmente avanÃado e submetidas à quimioterapia neoadjuvante / Linfonodo sentry in cancer in breast local advanced pÃs-quimioterapia neoadjuvantePaulo Henrique Walter de Aguiar 27 December 2007 (has links)
CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior / estudar o linfonodo sentinela em pacientes portadoras de cÃncer na mama localmente avanÃado e que foram submetidos a quimioterapia neoadjuvante, compararando-o com os linfonodos axilares nÃo-sentinelas. Verificar a taxa de identificaÃÃo do linfonodo sentinela nestas pacientes, assim como estimar a sensibilidade, especificidade, falso-negativo, valor preditivo negativo e acurÃcia do mÃtodo. Metodologia: estudo transversal de validaÃÃo de teste diagnÃstico, envolvendo 34 pacientes oriundas do AmbulatÃrio da Maternidade-Escola Assis Chateaubriand. As pacientes portadoras de cÃncer na mama localmente avanÃado foram submetidas a quimioterapia neoadjuvante e aquelas que apresentaram axila clinicamente negativa para metÃstase de cÃncer de mama foram submetidas a biopsia do linfonodo sentinela e linfadenectomia axilar, utilizando administraÃÃo subareolar de azul patente, e este, apÃs sua identificaÃÃo, foi estudado mediante o exame de citologia de contato e parafina e comparado com conteÃdo linfÃtico axilar nÃo-sentinela. Realizada anÃlise descritiva e anÃlise dos testes utilizando teste t de Student, as proporÃÃes dos testes foram consideradas significativamente diferentes quando a probabilidade de estas serem semelhantes foi menor ou igual a 0,05. Resultados: Quando foi testada a citologia de contato intra-operatÃrio e parafina linfonodo sentinela e padrÃo-ouro os linfonodos sentinelas e nÃo-sentinelas, a taxa de identificaÃÃo do linfonodo sentinela foi de 85,3%. A sensibilidade foi de 84,62% e a especificidade de 100%. O valor preditivo negativo de 87,99% e taxa de falso-negativo de 12,01%. A acurÃcia foi de 92,77%. Dado observado na amostra foi a diferenÃa significativa do nÃmero mÃdio do total de linfonodos observados entre o grupo de pacientes com tempo de intervenÃÃo cirÃrgica Ãtimo p=0,037. Quando foi testada apenas a citologia de contato intraoperatÃria do linfonodo sentinela e padrÃo-ouro, a parafina dos linfonodos sentinelas e nÃo-sentinelas a sensibilidade foi de 62,50%, a especificidade de 100%, valor preditivo negativo de 75,04%, falso-negativo de 24,96% e acurÃcia de 82,38%. ConclusÃo: a citologia de contato intraoperatÃrio do linfonodo sentinela para pacientes com cÃncer de mama localmente avanÃados com axila clinicamente negativa apÃs quimoterapia neoadjuvante apresenta baixa sensibilidade e taxa de falso-negativo elevada. / Aims: investigating sentinel lymph node in patients with locally advanced breast cancer whom were administered neoadjuvant chemotherapy, by contrast to non-sentinel axillary lymph nodes. Verifying the identification of sentinel lymph node rate in these patients, as well as estimating methodâs sensibility, specificity, false-negative and accuracy. Methodology: transversal study for validation of a diagnostic test, with 34 patients from Maternidade-Escola Assis Chateaubriandâs ambulatory. The locally advanced breast cancer patients were treated with neoadjuvant chemotherapy, and the ones with cancer metastasis clinically negative axilla were submitted to sentinel lymph node biopsy and axillary lymphadenectomy, using subareolar patent blue, and, after its identification, it was studied with contact cytology and paraffin and it was compared with non-sentinel axillary lymph content. The descriptive analysis of tests used Studentâs t-test, and tests proportions were considered significantly different when their similarity possibility was less or equal to 0.05. Results: When intraoperatory contact cytology study, paraffin sentinel lymph node and gold standar, sentinel and non-sentinel lymph nodes, the sentinel lymph node identification rate was 85.3%. Sensibility was 84.62%, and specificity was 100%. The predictive negative value was 87.99%, and the false-negative rate was 12.01%. Accuracy rate was 92.77%. The study points the significant difference of total lymph nodes mean number observed among the group with optimal time of surgical intervention p=0.037. When only the intraoperatory contact cytology of sentinel lymph node and gold pattern, the paraffin of sentinel and non-sentinel lymph nodes, sensibility was 62.50%, specificity 100%, predictive negative value 75.04%, false-negative 24.96%, and accuracy 82.38%. Conclusion: intraoperatory contact cytology of sentinel lymph node to locally advanced breast cancer patients with clinically negative axilla after neoadjuvant chemotherapy presents low sensibility and high false-negative rates.
|
Page generated in 0.0625 seconds